SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Xingbo Wang who wrote (155)4/17/1997 10:04:00 AM
From: David Richardson   of 305
 
Skepticism is justified, but a lot of people who have looked into this have come away with the impression that IMUL is on to something big, i.e. using molecular biology to stop the allergic reaction from happening in the first place, not just treating symptoms.

My understanding is that the main objection of the FDA involves the placebo effect, which is getting in the way of demonstrating the effectiveness of the vaccines. We have to assume that these matters will be dealt with in the trials this summer, since the FDA has been intimately involved in their design (as I understand it).

I will bring this up, or it will presumably come up, at the annual meeting on 13 May and I will report back to you.

Best regards.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News